Delflex w Dextrose 4.25% in a plastic container is an intravenous solution used for hydration and electrolyte replenishment [1]. It is a sterile, non-pyrogenic solution intended for single-use administration [1].
What is the purpose of Delflex w Dextrose 4.25%?
Delflex w Dextrose 4.25% is indicated to restore extracellular fluid and provide carbohydrate calories [1]. The dextrose component provides a source of calories, while the electrolyte content helps to maintain fluid and electrolyte balance in the body [1]. It can be used in situations requiring fluid replacement, such as dehydration or electrolyte imbalances.
What are the components of Delflex w Dextrose 4.25%?
The solution contains dextrose (4.25% w/v) as the carbohydrate source [1]. The exact electrolyte composition, such as sodium, potassium, and chloride levels, would be detailed in the product's official labeling and is crucial for its therapeutic use.
Who manufactures Delflex w Dextrose 4.25%?
This product is manufactured by Baxter Healthcare Corporation [1].
What are the administration guidelines for Delflex w Dextrose 4.25%?
The administration of Delflex w Dextrose 4.25% should be carried out by a healthcare professional [1]. Dosage and rate of administration depend on the patient's clinical condition, age, weight, and response [1]. It is typically administered intravenously [1].
What precautions should be taken when using Delflex w Dextrose 4.25%?
Careful consideration should be given to patients with conditions such as severe renal impairment, hypervolemia, or specific electrolyte abnormalities, as these may affect the suitability and safe administration of the solution [1]. Close monitoring of fluid balance, electrolyte levels, and acid-base status is recommended during administration [1].
Are there any contraindications for Delflex w Dextrose 4.25%?
Contraindications would typically include hypersensitivity to the components of the solution [1]. Specific contraindications may be outlined in the product's official prescribing information and should be reviewed by a healthcare provider before administration.
What are the potential risks associated with Delflex w Dextrose 4.25%?
Potential risks can include fluid overload, electrolyte imbalances, and reactions at the infusion site [1]. The dextrose content may also pose risks for patients with hyperglycemia [1].
Where can I find more detailed product information?
Detailed information regarding Delflex w Dextrose 4.25%, including complete prescribing information, indications, contraindications, warnings, precautions, and adverse reactions, can be found in the product's official package insert or by consulting a healthcare professional [1].
Sources:
[1] https://www.drugpatentwatch.com/drugs/delflex-w-dextrose-4-25-in-plastic-container-230017